Medelis
2 SlideShares 8 Seguidores
Personal Information
Organização/Local de trabalho
Nashville, TN United States
Setor
Medical / Health Care / Pharmaceuticals
Site
www.medelis.com
Sobre
Medelis is a boutique oncology CRO focused on phase I through phase III oncology trials in North America and Europe. We specialize in oncology, and our entire team has deep oncology trial experience and expertise.
Detalhes do contato
Marcadores
biotech oncology cro pharma biotechnology medelis pharmaceutical clinicalresearch contractresearch clinical research clinicaltrials health medicine pre-clinical contract trial pharmaceuticals patientsafety preclinical clinical research phase ii cytel phase i clinical trials adaptive trial dan-von-hoff cancer drug development trials phase i ii clinical_trial phase_i contract_research drug_development dan_von_hoff phase1
Ver mais
  • Apresentações
  • Documentos
  • Infográficos
Mais recentes Mais populares

Oncological Emergencies: Hypercalcaemia

Phil Mayor • Há 15 anos

Patient Problem-Solving on the Web: How do Patients Use Web Forums to Cope with Chronic Disease? [4 1530 Aud Billman]

Gunther Eysenbach • Há 15 anos

The Lost Art Of Phase I Oncology Trials

Medelis • Há 15 anos

BioEntrepreneurship: The Business of Biotech

MaRS Discovery District • Há 16 anos

Future trends and perspectives in modern pharmaceutical biotechnology

inemet • Há 16 anos

Optimizing Preclinical Proof of Concept

MaRS Discovery District • Há 16 anos

Open Data In Clinical Research

Martin Fenner • Há 15 anos

Logistics and Practicalities of Phase I Clinical Research

MaRS Discovery District • Há 16 anos

Clinical Trials Registry

biinoida • Há 15 anos

The Cochrane Collaboration Colloquium: Global opportunities and challenges for trial registration: Update from the WHO International Clinical Trials Registry Platform

Cochrane.Collaboration • Há 16 anos

Clinical Trials in India

vaatsalya • Há 16 anos

Clinical Trials Strategy: The Clinical Development Plan

MaRS Discovery District • Há 16 anos

Estimating the Maximum Safe Starting Dose for First-in-Human Clinical Trials

MaRS Discovery District • Há 16 anos

How web 2.0 is changing medicine

Victor Castilla • Há 17 anos

Patient Safety in Clinical Trials

Medelis • Há 15 anos

Medicine 2.0 with the eye of a medical student blogger

Bertalan Mesko, MD • Há 15 anos

Beyond the Business Plan - Managing unexpected risks in biotechnology business development

thinkBiotech • Há 15 anos

Construction of Expertise in the Age of the Internet: Psychotropic Drug Knowledge in Consumer-Constructed Websites

Shannon Hughes • Há 15 anos

Science and Web2.0

Ian Mulvany • Há 16 anos